PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Discovering a 'THRIL' that correlates with severity of Kawasaki disease

2013-12-27
(Press-News.org) Contact information: Susan Gammon
858-795-5012
Sanford-Burnham Medical Research Institute
Discovering a 'THRIL' that correlates with severity of Kawasaki disease

LA JOLLA, Calif., December 26, 2013 – Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alpha—a potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.

Noncoding RNAs as key regulators of immune response

Large noncoding RNA corresponds to the parts of the genome that do not code for protein.

"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."

Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the disease—when TNF-alpha levels are at their highest.

The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.



INFORMATION:

This research was funded in part by the National Institutes of Health grants AI41404, AI43198, and DA30199, and Integrating Data for Analysis, Anonymization, and Sharing grant U54HL108460.

The study was co-authored by Zhonghan Li, Sanford-Burnham Medical Research Institute; Ti chun Chao, Sanford-Burnham Medical Research Institute; Kung-Yen Chang, Sanford-Burnham Medical Research Institute; Nianwei Lin, Sanford-Burnham Medical Research Institute; Veena Patil, Sanford-Burnham Medical Research Institute; Chisato Shimizu, Department of Pediatrics, Rady Children's Hospital San Diego and UC San Diego; Steven R. Head, The Scripps Research Institute; Jane C. Burns, Department of Pediatrics, Rady Children's Hospital San Diego and UC San Diego; and Tariq M. Rana, Sanford-Burnham Medical Research Institute and UC San Diego.

About TNF-alpha

TNF-alpha is a signaling protein produced mainly by macrophages in the body's response to infection. TNF-alpha is known to drive inflammation and tissue destruction in immune mediated diseases. Anti-TNF drugs are used to control inflammatory diseases such rheumatoid arthritis and psoriasis.

About Macrophages

Macrophages are the first line of defense for the immune system, and are considered to be the "bottom feeders" of white blood cells. They work by ingesting many cells and depending on the type of cell ingested they send signals—such as TNF-alpha—to alert the rest of the immune system that it's time to defend the body.

About Kawasaki Disease

Kawasaki disease is a rare childhood disease that involves inflammation of the blood vessels. In some cases, the disease affects the coronary arteries, leading to serious heart problems. Kawasaki disease affects children of all races, genders, and ages. It occurs most often in children of Asian and Pacific Island descent. Symptoms include red eyes, red lips, and redness on the palm of their hands and soles of their feet—all signs of inflamed blood vessels.

The cause of the disease is unknown, and it can't be prevented. Although the disease has a good prognosis with treatment, it can lead to death from coronary artery aneurysm in a small percentage of patients.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of diseases and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery and stem-cell technologies. Sanford-Burnham is a nonprofit, independent institute that employs 1,200 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at http://www.sanfordburnham.org.



ELSE PRESS RELEASES FROM THIS DATE:

Who is using MyPlate?

2013-12-27
Who is using MyPlate? Food preferences, cooking ability, involvement of children in food preparation, nutritional knowledge, and prior familiarity with MyPyramid were predictors of MyPlate awareness and use Most Americans know about MyPyramid – the triangle ...

BU researchers explore possible link between cognitive depressive symptoms and antiretroviral therapy uptake

2013-12-21
BU researchers explore possible link between cognitive depressive symptoms and antiretroviral therapy uptake Researchers from Boston University's School of Medicine (BUSM) and College of Arts and Sciences (CAS) found that among HIV-infected Russian drinkers, ...

Wayne State University physicists publish observation of the 'Charming Socialites'

2013-12-21
Wayne State University physicists publish observation of the 'Charming Socialites' DETROIT — Protons and neutrons, the particles in an atomic nucleus, are made of smaller pieces called "quarks." Some types of quarks ...

Starless cloud cores reveal why some stars are bigger than others

2013-12-21
Starless cloud cores reveal why some stars are bigger than others Massive stars – those at least 8 times the mass of our Sun – present an intriguing mystery: how do they grow so large when the vast majority of stars in the Milky Way are considerably smaller? To ...

Researchers find potential new treatment approach for pancreatic cancer

2013-12-21
Researchers find potential new treatment approach for pancreatic cancer Scientists from The University of Manchester -- part of Manchester Cancer Research Centre believe they have discovered a new way to make chemotherapy treatment more effective ...

Wayne State cholesterol study shows algal extracts may counter effects of high fat diets

2013-12-21
Wayne State cholesterol study shows algal extracts may counter effects of high fat diets Health Enhancement Products, Inc. (OTC.BB:HEPI.OB – News), in conjunction with Wayne State University's Department of Nutrition ...

Staph stoppers

2013-12-21
Staph stoppers New vaccine from University of Iowa protects against lethal pneumonia caused by staph bacteria University of Iowa researchers have developed a new vaccine that protects against lethal pneumonia caused by Staphylococcus aureus (staph) bacteria, including ...

A wrong molecular turn leads down the path to Type 2 diabetes

2013-12-21
A wrong molecular turn leads down the path to Type 2 diabetes Computing resources at the U.S. Department of Energy's (DOE) Argonne National Laboratory have helped researchers better grasp how proteins misfold to create the tissue-damaging structures that ...

UNL research raises concerns about global crop projections

2013-12-21
UNL research raises concerns about global crop projections 30 percent of world's corn, rice and wheat crop land may be 'maxed out' LINCOLN, Neb. — About 30 percent of the major global cereal crops – rice, wheat and corn – may have reached their maximum possible ...

Penn researchers grow liquid crystal 'flowers' that can be used as lenses

2013-12-21
Penn researchers grow liquid crystal 'flowers' that can be used as lenses A team of material scientists, chemical engineers and physicists from the University of Pennsylvania has made another advance in their effort to use liquid crystals as a medium for assembling ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Discovering a 'THRIL' that correlates with severity of Kawasaki disease